Comparison of Benign, Borderline, and Malignant Ovarian Seromucinous Neoplasms on MR Imaging
View abstract on PubMed
Summary
This summary is machine-generated.MRI can help differentiate ovarian seromucinous neoplasms. Malignant tumors show thicker mural nodules with lower apparent diffusion coefficient (ADC) values compared to benign or borderline types.
Area Of Science
- Radiology
- Oncology
- Gynecologic Pathology
Background
- Ovarian seromucinous neoplasms present a diagnostic challenge.
- Accurate differentiation is crucial for appropriate patient management.
Purpose Of The Study
- To compare MRI findings in benign, borderline, and malignant ovarian seromucinous neoplasms.
- To identify imaging features that distinguish these tumor types.
Main Methods
- Retrospective analysis of MRI data from 24 patients.
- Evaluation of tumor size, morphology, mural nodule characteristics (height, ADC values, T2 ratios), cyst content ratios, tumor markers, and endometriosis.
- Statistical comparison using Kruskal-Wallis and Fisher-Freeman-Halton exact tests.
Main Results
- Papillary architecture with internal branching was common in benign (57%) and borderline (92%) but rare in malignant (17%) neoplasms.
- Malignant neoplasms had significantly taller mural nodules with lower apparent diffusion coefficient (ADC) values compared to benign and borderline tumors.
- Malignant mural nodules showed significantly lower T2 ratios than benign ones.
Conclusions
- Papillary architecture and fewer mural nodules suggest benign or borderline neoplasms.
- Increased mural nodule height and lower ADC values are indicators of malignancy.
- The predominant intermediate-risk time-intensity curve (TIC) pattern across all groups highlights the complexity of MRI diagnosis for these neoplasms.

